Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Revenues:        
Revenues $ 2,432,608 $ 2,288,676 $ 8,140,919 $ 6,725,144
Costs and expenses:        
Costs of revenues 1,005,346 892,091 3,255,358 2,613,877
Research and development 328,276 285,189 979,617 808,373
Selling, general and administrative 238,393 216,489 735,469 623,229
Interest expense 74,774 39,978 223,449 116,142
Loss on extinguishment of debt 0 0 13,286 0
Other expense (income), net (14,864) 8,644 (79,944) 23,985
Income before income taxes 800,683 846,285 3,013,684 2,539,538
Provision for income taxes 102,846 115,625 310,987 22,876
Net income 697,837 730,660 2,702,697 2,516,662
Less: Net income attributable to non-controlling interest 0 88 74 229
Net income attributable to KLA $ 697,837 $ 730,572 $ 2,702,623 $ 2,516,433
Net income per share attributable to KLA        
Basic (in dollars per share) $ 5.06 $ 4.87 $ 19.26 $ 16.64
Diluted (in dollars per share) $ 5.03 $ 4.83 $ 19.16 $ 16.52
Weighted-average number of shares:        
Basic (in shares) 137,865 150,145 140,349 151,250
Diluted (in shares) 138,645 151,186 141,073 152,346
Product        
Revenues:        
Revenues $ 1,903,484 $ 1,800,659 $ 6,562,501 $ 5,326,316
Service        
Revenues:        
Revenues $ 529,124 $ 488,017 $ 1,578,418 $ 1,398,828